Doctors performed the first-ever FDA approved Schwann cell transplantation in a patient with a new spinal cord injury. The procedure is a Phase 1 clinical trial designed to evaluate the safety and feasibility of transplanting the patient’s own Schwann cells.
A new drug can lure stem cells to damaged tissue and locations, improving treatment efficacy. The drug could be used to help recruit stem cells to sites damaged by neurodegenerative diseases.
in a mouse model of Rett syndrome, researchers were able to reverse abnormalities in brain activity and improve neurological function by treating animals with an FDA-approved anesthesia drug, ketamine.
Researchers suggest the overexpression of a protein called alpha-synuclein appears to disrupt vital recycling processes in neurons. The study may have major implications for more fully understanding the causes and mechanisms of Parkinson’s disease.
A nationwide clinical trial for a new type treatment that could offer help to those suffering from Duchenne Muscular Dystrophy, a devastating neuromuscular disease.
Long-term aim is to develop new treatments to block the spread of damaged proteins in the brain. Van Andel Institute...
Researchers announced that the UK’s first operation to tackle heart failure with a novel nerve-stimulating device will be performed today. The implantable device operates by stimulating the vagus nerve on the right side of the neck.
Scientists have unlocked the secrets of the zebrafish’s ability to heal its spinal cord after injury, in research that could...
A recent study finds that a new compound reverses many of the major symptoms associated with Fragile X syndrome (FXS),...
The biological role of a gene variant implicated in multiple sclerosis (MS) has been determined by researchers at Oxford University. The researchers investigated one particular genetic variant - found in a gene called TNFRSF1A - which has previously been associated with the risk of developing MS.
Gene involved in dementia affects the insulin pathway, reports biology professor Chris Li and colleagues. In recent years it became...
In three adults, repeat dose safely improves vision. Gene therapy for congenital blindness has taken another step forward, as researchers...